Krishgen is the only manufacturer of ELISA for pharmacokinetic studies of BsAbs, with 40+ drug targets in a sensitive, highly specific ELISA format.
Bispecific T-Cell Engaging (BiTE) Antibodies: A Promising Cancer Therapy
![Bispecific T-Cell Engaging (BiTE) Antibodies: A Promising Cancer Therapy Bispecific T-Cell Engaging (BiTE) Antibodies: A Promising Cancer Therapy](https://www.caltagmedsystems.co.uk/information/wp-content/uploads/krishgen-blog-post-bsAbs-600x300.png)
Krishgen is the only manufacturer of ELISA for pharmacokinetic studies of BsAbs, with 40+ drug targets in a sensitive, highly specific ELISA format.
Leinco manufactures an extensive range of primary antibodies with the highest purity specifications available in the research products industry.
PhenoCycler-Fusion (CODEX)® technology target subsets of an antibody panel via repetitive imaging cycles, revealing 40+ biomarkers in a tissue section.
Leinco Technologies offers a wide range of second step reagents including secondary antibodies, streptavidin and UltraAvidin™.
Leinco Technologies provides in vivo functional grade antibodies with the highest purity standards in the industry: In vivo GOLDTM & In vivo PLATINUMTM.
Isotype control antibodies optimise study performance & data analysis in therapeutic antibody research, which is key to drug development.
ProSci-Inc’s RIP3/RIPK3 antibody (Cat. No. PSI-2283) is widely cited with as many as 171 citations on CiteAb and 165 citations on Bioz.
OZ Biosciences offers solutions to deliver functional Proteins and Antibodies into living cells.
The significance of antibody-based in vivo studies For both research and therapeutic purposes, antibodies can be used to affect cellular processes in vivo and are referred to as functional/in vivo grade antibodies. There is a wide range of applications for
mAbs (biosimilars) as tools to research novel new therapies and uncover effective off-target application.